Michael Becker, MD, Oncology, Rochester, NY, Strong Memorial Hospital of the University of Rochester

MichaelW.BeckerMD

Oncology Rochester, NY

Hematologic Oncology

Associate Chief- Hematology, Professor of Medicine, Director- BMT/ Leukemia Program University of Rochester Medical Center

Dr. Becker is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Becker's full profile

Already have an account?

Summary

  • Dr. Michael Becker is an oncologist in Rochester, NY and is affiliated with multiple hospitals in the area, including Strong Memorial Hospital of the University of Rochester and Highland Hospital. He received his medical degree from University of Cincinnati College of Medicine and has been in practice 21 years. He specializes in hematologic oncology and is experienced in amyloidosis, hematologic oncology, bone marrow failure syndromes, myelodysplasia, and myelofibrosis.

Education & Training

  • U MichiganFellowship, Hematology and Oncology (IM), 2002
  • University of Michigan Hospitals and Health Centers
    University of Michigan Hospitals and Health CentersResidency, 1999
  • University of Michigan Hospitals and Health Centers
    University of Michigan Hospitals and Health CentersInternship, Internal Medicine, 1996 - 1997
  • University of Cincinnati College of Medicine
    University of Cincinnati College of MedicineClass of 1996
  • University of CincinnatiM.S., Chemistry, 1988 - 1991
  • University of CincinnatiB.S., Chemistry, 1984 - 1988

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2005 - 2022
  • MI State Medical License
    MI State Medical License 1999 - 2009
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
  • Wilmot Cancer Research Fellowship 2007
  • Bushwell Fellowship University of Rochester Department of Internal Meidcine, 2007
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • SWOG S0910: a phase 2 trial of clofarabine/cytarabine/epratuzumab for relapsed/refractory acute lymphocytic leukaemia  
    Advani AS, McDonough S, Coutre S, Wood B, Radich J, Mims M, O'Donnell M, Elkins S, Becker M, Othus M, Appelbaum FR, Br J Haematol, 1/1/2014
  • Selective activity of the histone deacetylase inhibitor AR-42 against leukemia stem cells: a novel potential strategy in acute myeloid leukemia  
    Guzman ML, Yang N, Sharma KK, Balys M, Corbett CA, Jordan CT, Becker MW, Steidl U, Abdel-Wahab O, Levine RL, Marcucci G, Roboz GJ, Hassane DC, Mol Cancer Ther, 1/1/2014
  • Targeting aberrant glutathione metabolism to eradicate human acute myelogenous leukemia cells  
    Pei S, Minhajuddin M, Callahan KP, Balys M, Ashton JM, Neering SJ, Lagadinou ED, Corbett C, Ye H, Liesveld JL, O'Dwyer KM, Li Z, Shi L, Greninger P, Settleman J, Benes..., J Biol Chem, 1/22/2013
  • Join now to see all

Books/Book Chapters

Abstracts/Posters

  • A Specific Mesenchymal Stem and Progenitor Cell (MSPC) Subpopulation with a Multi-Potent Gene Signature Is Transcriptionally Altered in the Setting of Myelodysplastic ...
    Michael W. Becker, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Increased Early Mortality after Fludarabine and Melphalan Conditioning with Peripheral Blood Grafts in Haploidentical SCT with Post-Transplant Cyclophosphamide
    Michael W. Becker, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Disruption Of The Hematopoietic Stem and Progenitor Cell Pool and Bone Marrow Microenvironment In a Murine Model Of Myelodysplastic Syndrome.
    Balderman, S. R., Frisch, B.J., LaMere, M.W., Goodman, A.N.., Becker, M.W. and Calvi, L.M., American Society of Hematology Annual Meeting, 1/1/2014
  • Join now to see all

Lectures

  • Qualitative Study of Factors That Influence Treatment Decision-Making Among Community Oncologists and Older Patients with Acute Myeloid Leukemia 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Access and Referral Barriers to Autologous and Allogeneic Hematopoietic Cell Transplantation in Adult Patients with Cancer: A Systematic Review with a Specific Focus o... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Other

  • Stem Cells: Finding the Real Culprits in Cancer. 
    Clarke, M.F., and Becker, M.W.
    1/1/2006

Press Mentions

  • Studies Show That Treatment of Leukemia Can Feed and Capture Hidden Cells
    Studies Show That Treatment of Leukemia Can Feed and Capture Hidden CellsMay 28th, 2021
  • Leukemia Treatment Can Bait and Capture Cells in Hiding, Research Shows
    Leukemia Treatment Can Bait and Capture Cells in Hiding, Research ShowsMay 28th, 2021

Committees

  • committee member, American Society of Hematology Committee on Myeloid Neoplasia 2012 - Present

Hospital Affiliations